From: Role of osteoprotegerin rs3102735 gene polymorphism in acute ischemic stroke patients
Patients (n = 50) | Controls (n = 50) | Test of sig. | p | |
---|---|---|---|---|
Age (years) | ||||
Mean ± SD | 56.26 ± 6.81 | 56.14 ± 7.0 | t = 0.087 | 0.931 |
Median (Min.–Max.) | 56.0 (44.0–73.0) | 55.0 (44.0–73.0) | ||
Sex | n (%) | n (%) | ||
Male | 18 (36.0%) | 22 (44.0%) | χ2 = 0.667 | 0.414 |
Female | 32 (64.0%) | 28 (56.0%) | ||
Risk factors | n (%) | n (%) | ||
Smoking | 32 (64.0%) | 11 (22.0%) | 17.993* | < 0.001* |
Previous stroke | 7 (14.0%) | 0 (0.0%) | 7.527 | FEp = 0.012* |
Previous ischemic heart disease | 8 (16.0%) | 2 (4.0%) | 4.0* | 0.046* |
Hypertension | 32 (64.0%) | 11 (22.0%) | 17.993* | < 0.001* |
Diabetes mellitus | 27 (54.0%) | 8 (16.0%) | 15.868* | < 0.001* |
Lipid profile (mg/dl) | Mean ± SD | Mean ± SD | ||
Triglyceride | 259.60 ± 67.09 | 108.70 ± 29.55 | t = 14.555* | < 0.001* |
Total cholesterol | 261.08 ± 42.17 | 193.64 ± 16.98 | U = 26.50* | < 0.001* |
Low density lipoprotein | 172.26 ± 14.20 | 132.40 ± 18.54 | U = 71.0* | < 0.001* |
High density lipoprotein | 38.34 ± 8.67 | 43.74 ± 5.15 | t = 3.787* | < 0.001* |
Serum uric acid | 6.52 ± 1.79 | 3.67 ± 1.24 | U = 278.0* | < 0.001* |
C-reactive protein (mg/dl) | 9.69 ± 2.62 | 3.75 ± 1.21 | U = 79.0* | < 0.001* |